Supplementary Figure S5 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer

Nan Ding,A-Bin You,Hu Yang,Guo-Sheng Hu,Chun-Ping Lai,Wen Liu,Feng Ye
DOI: https://doi.org/10.1158/1078-0432.22658851
2023-01-01
Abstract:Figure S5: EP300 is lowly expressed in CRC tissues and positively correlated with RERE.
What problem does this paper attempt to address?